Chitinase Dependent Control of Protozoan Cyst Burden in the Brain

PLoS Pathogens

Volumn 8, Issue 11, 2012, Pages

  Nance, J Philip ^a   Vannella, Kevin M ^b   Worth, Danielle ^a   David, Clément ^a   Carter, David ^c   Noor, Shahani ^a   Hubeau, Cedric ^d   Fitz, Lori ^d   Lane, Thomas E ^e   Wynn, Thomas A ^b   Wilson, Emma H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d PFIZER INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOSAMIDIN; CHEMOKINE RECEPTOR CXCR3; CHITINASE; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CELL INTERACTION; CONTROLLED STUDY; CYST (RESTING STAGE); ENZYME ACTIVITY; ENZYME ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PARASITE CLEARANCE; PARASITE LOAD; PARASITE LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; BRAIN; BRAIN DISEASES; CHITINASE; CYSTS; MACROPHAGES; MICE; TH1 CELLS; TOXOPLASMA; TOXOPLASMOSIS;

PROTOZOA; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 84870789676     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002990     Document Type: Article

References (91)

1. Bohne W, Heesemann J, Gross U, (1994) Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun 62: 1761-1767.
2. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, et al. (1994) Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 153: 2533-2543.
3. Gazzinelli RT, Denkers EY, Sher A, (1993) Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infect Agents Dis 2: 139-149.
4. Luft BJ, Remington JS, (1984) Acute Toxoplasma infection among family members of patients with acute lymphadenopathic toxoplasmosis. Arch Intern Med 144: 53-56.
5. Luft BJ, Remington JS, (1992) Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15: 211-222.
6. Drogemuller K, Helmuth U, Brunn A, Sakowicz-Burkiewicz M, Gutmann DH, et al. (2008) Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J Immunol 181: 2683-2693.
7. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, et al. (1996) In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157: 798-805.
8. Wilson EH, Harris TH, Mrass P, John B, Tait ED, et al. (2009) Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesis-associated system of reticular fibers. Immunity 30: 300-311.
9. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA, (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63-74.
10. Ploix CC, Noor S, Crane J, Masek K, Carter W, et al. (2011) CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection. Brain Behav Immun 25: 883-896.
11. Wilson EH, Weninger W, Hunter CA, (2010) Trafficking of immune cells in the central nervous system. Journal of Clinical Investigation 120: 1368-1379.
12. Kim SK, Boothroyd JC, (2005) Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence. J Immunol 174: 8038-8048.
13. Radke JR, Guerini MN, Jerome M, White MW, (2003) A change in the premitotic period of the cell cycle is associated with bradyzoite differentiation in Toxoplasma gondii. Mol Biochem Parasitol 131: 119-127.
14. Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A, (1992) Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 149: 175-180.
15. Ferguson DJ, Hutchison WM, (1987) An ultrastructural study of the early development and tissue cyst formation of Toxoplasma gondii in the brains of mice. Parasitol Res 73: 483-491.
16. Burke JM, Roberts CW, Hunter CA, Murray M, Alexander J, (1994) Temporal differences in the expression of mRNA for IL-10 and IFN-gamma in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii. Parasite Immunol 16: 305-314.
17. Suzuki Y, Wang X, Jortner BS, Payne L, Ni Y, et al. (2010) Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am J Pathol 176: 1607-1613.
18. Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, et al. (1997) Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 159: 1903-1908.
19. John B, Ricart B, Tait Wojno ED, Harris TH, Randall LM, et al. (2011) Analysis of behavior and trafficking of dendritic cells within the brain during toxoplasmic encephalitis. PLoS Pathog 7: e1002246.
20. Redente EF, Higgins DM, Dwyer-Nield LD, Orme IM, Gonzalez-Juarrero M, et al. (2010) Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol 88: 159-168.
21. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, et al. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 175: 342-349.
22. Stout RD, Suttles J, (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 76: 509-513.
23. Galli SJ, Borregaard N, Wynn TA, (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 12: 1035-1044.
24. Murray PJ, Wynn TA, (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737.
25. Middleton MK, Zukas AM, Rubinstein T, Kinder M, Wilson EH, et al. (2009) 12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis. Infect Immun 77: 5690-5700.
26. Gazzinelli RT, Hayashi S, Wysocka M, Carrera L, Kuhn R, et al. (1994) Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. J Eukaryot Microbiol 41: 9S.
27. Melzer T, Duffy A, Weiss LM, Halonen SK, (2008) The gamma interferon (IFN-gamma)-inducible GTP-binding protein IGTP is necessary for toxoplasma vacuolar disruption and induces parasite egression in IFN-gamma-stimulated astrocytes. Infect Immun 76: 4883-4894.
28. Nathan C, Shiloh MU, (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 97: 8841-8848.
29. Scharton-Kersten TM, Yap G, Magram J, Sher A, (1997) Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185: 1261-1273.
30. Schluter D, Deckert-Schluter M, Lorenz E, Meyer T, Rollinghoff M, et al. (1999) Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. J Immunol 162: 3512-3518.
31. Ferguson DJ, Hutchison WM, Pettersen E, (1989) Tissue cyst rupture in mice chronically infected with Toxoplasma gondii. An immunocytochemical and ultrastructural study. Parasitol Res 75: 599-603.
32. Li H, Gang Z, Yuling H, Luokun X, Jie X, et al. (2006) Different neurotropic pathogens elicit neurotoxic CCR9- or neurosupportive CXCR3-expressing microglia. J Immunol 177: 3644-3656.
33. Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, et al. (2004) CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci 24: 8500-8509.
34. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, et al. (2002) IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168: 3195-3204.
35. Harris TH, Banigan EJ, Christian DA, Konradt C, Tait Wojno ED, et al. (2012) Generalized Levy walks and the role of chemokines in migration of effector CD8+ T cells. Nature 486: 545-548.
36. Khan IA, MacLean JA, Lee FS, Casciotti L, DeHaan E, et al. (2000) IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12: 483-494.
37. Norose K, Kikumura A, Luster AD, Hunter CA, Harris TH, (2011) CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis. Invest Ophthalmol Vis Sci 52: 389-398.
38. Stein M, Keshav S, Harris N, Gordon S, (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292.
39. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, et al. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 101: 4560-4565.
40. Kzhyshkowska J, Gratchev A, Goerdt S, (2006) Stabilin-1, a homeostatic scavenger receptor with multiple functions. J Cell Mol Med 10: 635-649.
41. Kzhyshkowska J, Mamidi S, Gratchev A, Kremmer E, Schmuttermaier C, et al. (2006) Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 107: 3221-3228.
42. Park SY, Jung MY, Lee SJ, Kang KB, Gratchev A, et al. (2009) Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J Cell Sci 122: 3365-3373.
43. Kreider T, Anthony RM, Urban JF Jr, Gause WC, (2007) Alternatively activated macrophages in helminth infections. Curr Opin Immunol 19: 448-453.
44. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, et al. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 167: 6533-6544.
45. Rutschman R, Lang R, Hesse M, Ihle JN, Wynn TA, et al. (2001) Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J Immunol 166: 2173-2177.
46. El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, et al. (2008) Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 9: 1399-1406.
47. Jensen KD, Wang Y, Wojno ED, Shastri AJ, Hu K, et al. (2011) Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 9: 472-483.
48. Butcher BA, Fox BA, Rommereim LM, Kim SG, Maurer KJ, et al. (2011) Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog 7: e1002236.
49. Boothroyd JC, Black M, Bonnefoy S, Hehl A, Knoll LJ, et al. (1997) Genetic and biochemical analysis of development in Toxoplasma gondii. Philos Trans R Soc Lond B Biol Sci 352: 1347-1354.
50. Coppin A, Dzierszinski F, Legrand S, Mortuaire M, Ferguson D, et al. (2003) Developmentally regulated biosynthesis of carbohydrate and storage polysaccharide during differentiation and tissue cyst formation in Toxoplasma gondii. Biochimie 85: 353-361.
51. Da Silva CA, Hartl D, Liu W, Lee CG, Elias JA, (2008) TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. J Immunol 181: 4279-4286.
52. Reese TA, Liang HE, Tager AM, Luster AD, Van Rooijen N, et al. (2007) Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 447: 92-96.
53. Munder M, Eichmann K, Modolell M, (1998) Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 160: 5347-5354.
54. Lari R, Fleetwood AJ, Kitchener PD, Cook AD, Pavasovic D, et al. (2007) Macrophage lineage phenotypes and osteoclastogenesis-complexity in the control by GM-CSF and TGF-beta. Bone 40: 323-336.
55. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, et al. (2002) IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol 3: 7.
56. Boot RG, Blommaart EF, Swart E, Ghauharali-van der Vlugt K, Bijl N, et al. (2001) Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem 276: 6770-6778.
57. van Eijk M, van Roomen CP, Renkema GH, Bussink AP, Andrews L, et al. (2005) Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol 17: 1505-1512.
58. Renkema GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JM, (1995) Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J Biol Chem 270: 2198-2202.
59. McCreath KJG, GW, (1992) A rapid and sensitive microassay for detemrination of chitinolytic activity. Journal of Microbiological Methods 14: 229-237.
60. Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, et al. (2011) Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 73: 479-501.
61. Arora M, Chen L, Paglia M, Gallagher I, Allen JE, et al. (2006) Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells. Proc Natl Acad Sci U S A 103: 7777-7782.
62. Cai Y, Kumar RK, Zhou J, Foster PS, Webb DC, (2009) Ym1/2 promotes Th2 cytokine expression by inhibiting 12/15(S)-lipoxygenase: identification of a novel pathway for regulating allergic inflammation. J Immunol 182: 5393-5399.
63. Homer RJ, Zhu Z, Cohn L, Lee CG, White WI, et al. (2006) Differential expression of chitinases identify subsets of murine airway epithelial cells in allergic inflammation. Am J Physiol Lung Cell Mol Physiol 291: L502-511.
64. Nair MG, Cochrane DW, Allen JE, (2003) Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro. Immunol Lett 85: 173-180.
65. Raes G, De Baetselier P, Noel W, Beschin A, Brombacher F, et al. (2002) Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol 71: 597-602.
66. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
67. Saeij JP, Boyle JP, Boothroyd JC, (2005) Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol 21: 476-481.
68. Nair MG, Gallagher IJ, Taylor MD, Loke P, Coulson PS, et al. (2005) Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 73: 385-394.
69. Cozzarini E, Bellin M, Norberto L, Polese L, Musumeci S, et al. (2009) CHIT1 and AMCase expression in human gastric mucosa: correlation with inflammation and Helicobacter pylori infection. Eur J Gastroenterol Hepatol 21: 1119-1126.
70. Saeij JP, Boyle JP, Grigg ME, Arrizabalaga G, Boothroyd JC, (2005) Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect Immun 73: 695-702.
71. Contini C, Cultrera R, Seraceni S, Segala D, Romani R, et al. (2002) The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS. J Med Microbiol 51: 879-890.
72. Aguilar-Diaz H, Carrero JC, Arguello-Garcia R, Laclette JP, Morales-Montor J, (2011) Cyst and encystment in protozoan parasites: optimal targets for new life-cycle interrupting strategies? Trends Parasitol 27: 450-458.
73. Shapiro K, Largier J, Mazet JA, Bernt W, Ell JR, et al. (2009) Surface properties of Toxoplasma gondii oocysts and surrogate microspheres. Appl Environ Microbiol 75: 1185-1191.
74. Skariah S, McIntyre MK, Mordue DG, (2010) Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitol Res 107: 253-260.
75. Hsieh MF, Lai SL, Chen JP, Sung JM, Lin YL, et al. (2006) Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J Immunol 177: 1855-1863.
76. Stiles LN, Hardison JL, Schaumburg CS, Whitman LM, Lane TE, (2006) T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection. J Immunol 177: 8372-8380.
77. Stiles LN, Liu MT, Kane JA, Lane TE, (2009) CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination. Autoimmunity 42: 484-491.
78. Zhou J, Tang PC, Qin L, Gayed PM, Li W, et al. (2010) CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses. J Exp Med 207: 1951-1966.
79. Anthony RM, Urban JF Jr, Alem F, Hamed HA, Rozo CT, et al. (2006) Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 12: 955-960.
80. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, et al. (2010) The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11: 936-944.
81. Shibata Y, Foster LA, Bradfield JF, Myrvik QN, (2000) Oral administration of chitin down-regulates serum IgE levels and lung eosinophilia in the allergic mouse. J Immunol 164: 1314-1321.
82. Shibata Y, Metzger WJ, Myrvik QN, (1997) Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J Immunol 159: 2462-2467.
83. Wagner CJ, Huber S, Wirth S, Voehringer D, (2010) Chitin induces upregulation of B7-H1 on macrophages and inhibits T-cell proliferation. Eur J Immunol 40: 2882-2890.
84. Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, et al. (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304: 1678-1682.
85. Fitz LJ, DeClercq C, Brooks J, Kuang W, Bates B, et al. (2012) Acidic mammalian chitinase is not a critical target for allergic airway disease. Am J Respir Cell Mol Biol 46: 71-79.
86. Haroon F, Handel U, Angenstein F, Goldschmidt J, Kreutzmann P, et al. (2012) Toxoplasma gondii actively inhibits neuronal function in chronically infected mice. PLoS ONE 7: e35516.
87. Melzer TC, Cranston HJ, Weiss LM, Halonen SK, (2010) Host Cell Preference of Toxoplasma gondii Cysts in Murine Brain: A Confocal Study. J Neuroparasitology 1: pii: N100505.
88. Luo W, Aosai F, Ueda M, Yamashita K, Shimizu K, et al. (1997) Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR. J Parasitol 83: 1070-1074.
89. Noor S, Habashy AS, Nance JP, Clark RT, Nemati K, et al. (2010) CCR7-dependent immunity during acute Toxoplasma gondii infection. Infect Immun 78: 2257-2263.
90. Sharma SD, Mullenax J, Araujo FG, Erlich HA, Remington JS, (1983) Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol 131: 977-983.
91. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Hamilton TA, et al. (2001) The CXC chemokines IP-10 and Mig are essential in host defense following infection with a neurotropic coronavirus. Adv Exp Med Biol 494: 323-327.